ROCK1 Induces Endothelial-to-Mesenchymal Transition in Glomeruli to Aggravate Albuminuria in Diabetic Nephropathy

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Peng, Hui ^a   Li, Yuanqing ^a   Wang, Cheng ^a   Zhang, Jun ^a   Chen, Yanru ^a   Chen, Wenfang ^a   Cao, Jin ^b   Wang, Yanlin ^b   Hu, Zhaoyong ^b   Lou, Tanqi ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; ACTIN; ALPHA-SMOOTH MUSCLE ACTIN, MOUSE; CADHERIN; CD31 ANTIGEN; FASUDIL; GLUCOSE; LEUKOCYTE ANTIGEN; RHO KINASE; ROCK1 PROTEIN, HUMAN; VASCULAR ENDOTHELIAL CADHERIN;

ALBUMINURIA; ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CELL DIFFERENTIATION; CELL LINE; COMPLICATION; CYTOLOGY; DIABETIC NEPHROPATHY; DRUG EFFECTS; ENDOTHELIUM CELL; EXPERIMENTAL DIABETES MELLITUS; GENETICS; HUMAN; KIDNEY; MESENCHYMAL STROMA CELL; METABOLISM; MOUSE; MOUSE MUTANT; PATHOLOGY; PERMEABILITY; RAT; RETINA BLOOD VESSEL;

1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE; ACTINS; ALBUMINURIA; ANIMALS; ANTIGENS, CD; ANTIGENS, CD31; CADHERINS; CELL DIFFERENTIATION; CELL LINE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; ENDOTHELIAL CELLS; GLUCOSE; HUMANS; KIDNEY; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED C57BL; MICE, OBESE; PERMEABILITY; RATS; RETINAL VESSELS; RHO-ASSOCIATED KINASES;

EID: 84957558704     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep20304     Document Type: Article

References (34)

1. Reidy, K., Kang, H. M., Hostetter, T. & Susztak, K. Molecular mechanisms of diabetic kidney disease. J Clin Invest 124, 2333-2340 (2014).
2. Satchell, S. C. The glomerular endothelium emerges as a key player in diabetic nephropathy. Kidney Int 82, 949-951 (2012).
3. Zeisberg, E. M. et al. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med 13, 952-961 (2007).
4. Arciniegas, E., Frid, M. G., Douglas, I. S. & Stenmark, K. R. Perspectives on endothelial-to-mesenchymal transition: potential contribution to vascular remodeling in chronic pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 293, L1-8 (2007).
5. Ghosh, A. K. et al. Genetic deficiency of plasminogen activator inhibitor-1 promotes cardiac fibrosis in aged mice: involvement of constitutive transforming growth factor-beta signaling and endothelial-to-mesenchymal transition. Circulation 122, 1200-1209 (2010).
6. Zeisberg, E. M., Potenta, S. E., Sugimoto, H., Zeisberg, M. & Kalluri, R. Fibroblasts in kidney fibrosis emerge via endothelial-tomesenchymal transition. J Am Soc Nephrol 19, 2282-2287 (2008).
7. Xavier, S. et al. Curtailing endothelial TGF-beta signaling is sufficient to reduce endothelial-mesenchymal transition and fibrosis in CKD. J Am Soc Nephrol 26, 817-829 (2015).
8. Kanasaki, K. et al. Linagliptin-mediated DPP-4 inhibition ameliorates kidney fibrosis in streptozotocin-induced diabetic mice by inhibiting endothelial-to-mesenchymal transition in a therapeutic regimen. Diabetes 63, 2120-2131 (2014).
9. Li, J., Qu, X. & Bertram, J. F. Endothelial-myofibroblast transition contributes to the early development of diabetic renal interstitial fibrosis in streptozotocin-induced diabetic mice. Am J Pathol 175, 1380-1388 (2009).
10. Riento, K. & Ridley, A. J. Rocks: multifunctional kinases in cell behaviour. Nat Rev Mol Cell Biol 4, 446-456 (2003).
11. Wang, W. et al. Mitochondrial fission triggered by hyperglycemia is mediated by ROCK1 activation in podocytes and endothelial cells. Cell Metab 15, 186-200 (2012).
12. Peng, H. et al. Simvastatin alleviates hyperpermeability of glomerular endothelial cells in early-stage diabetic nephropathy by inhibition of RhoA/ROCK1. PLoS One 8, e80009 (2013).
13. Cheng, I. K. et al. GEF-H1 over-expression in hepatocellular carcinoma promotes cell motility via activation of RhoA signalling. J Pathol 228, 575-585 (2012).
14. Li, J., Song, Y., Wang, Y., Luo, J. & Yu, W. MicroRNA-148a suppresses epithelial-to-mesenchymal transition by targeting ROCK1 in non-small cell lung cancer cells. Mol Cell Biochem 380, 277-282 (2013).
15. Bhowmick, N. A. et al. Transforming growth factor-beta1 mediates epithelial to mesenchymal transdifferentiation through a RhoAdependent mechanism. Mol Biol Cell 12, 27-36 (2001).
16. Koska, J. et al. Exenatide Protects Against Glucose- and Lipid-Induced Endothelial Dysfunction: Evidence for Direct Vasodilation Effect of GLP-1 Receptor Agonists in Humans. Diabetes 64, 2624-2635 (2015).
17. Li, L. et al. C3a and C5a receptor antagonists ameliorate endothelial-myofibroblast transition via the Wnt/beta-catenin signaling pathway in diabetic kidney disease. Metabolism 64, 597-610 (2015).
18. Zhong, F. et al. Reduced Kruppel-like factor 2 expression may aggravate the endothelial injury of diabetic nephropathy. Kidney Int 87, 382-395 (2015).
19. Cheng, H., Wang, H., Fan, X., Paueksakon, P. & Harris, R. C. Improvement of endothelial nitric oxide synthase activity retards the progression of diabetic nephropathy in db/db mice. Kidney Int 82, 1176-1183 (2012).
20. Miyazawa, T. et al. Low nitric oxide bioavailability upregulates renal heparin binding EGF-like growth factor expression. Kidney Int 84, 1176-1188 (2013).
21. Daehn, I. et al. Endothelial mitochondrial oxidative stress determines podocyte depletion in segmental glomerulosclerosis. J Clin Invest 124, 1608-1621 (2014).
22. Xiao, L. et al. Tumor Endothelial Cells with Distinct Patterns of TGFbeta-Driven Endothelial-to-Mesenchymal Transition. Cancer Res 75, 1244-1254 (2015).
23. van Meeteren, L. A. & ten Dijke, P. Regulation of endothelial cell plasticity by TGF-beta. Cell Tissue Res 347, 177-186 (2012).
24. Herman-Edelstein, M. et al. Dedifferentiation of immortalized human podocytes in response to transforming growth factor-beta: a model for diabetic podocytopathy. Diabetes 60, 1779-1788 (2011).
25. Zent, R. & Pozzi, A. Angiogenesis in diabetic nephropathy. Semin Nephrol 27, 161-171 (2007).
26. Acevedo, L. M., Londono, I., Oubaha, M., Ghitescu, L. & Bendayan, M. Glomerular CD34 expression in short- and long-term diabetes. J Histochem Cytochem 56, 605-614 (2008).
27. Baelde, H. J. et al. Reduction of VEGF-A and CTGF expression in diabetic nephropathy is associated with podocyte loss. Kidney Int 71, 637-645 (2007).
28. Lindenmeyer, M. T. et al. Interstitial vascular rarefaction and reduced VEGF-A expression in human diabetic nephropathy. J Am Soc Nephrol 18, 1765-1776 (2007).
29. Kolavennu, V., Zeng, L., Peng, H., Wang, Y. & Danesh, F. R. Targeting of RhoA/ROCK signaling ameliorates progression of diabetic nephropathy independent of glucose control. Diabetes 57, 714-723 (2008).
30. Reiniger, N. et al. Deletion of the receptor for advanced glycation end products reduces glomerulosclerosis and preserves renal function in the diabetic OVE26 mouse. Diabetes 59, 2043-2054 (2010).
31. Haudek, S. B. et al. Rho kinase-1 mediates cardiac fibrosis by regulating fibroblast precursor cell differentiation. Cardiovasc Res 83, 511-518 (2009).
32. Dejana, E. Endothelial cell-cell junctions: happy together. Nat Rev Mol Cell Biol 5, 261-270 (2004).
33. Manickam, N., Patel, M., Griendling, K. K., Gorin, Y. & Barnes, J. L. RhoA/Rho kinase mediates TGF-beta1-induced kidney myofibroblast activation through Poldip2/Nox4-derived reactive oxygen species. Am J Physiol Renal Physiol 307, F159-171 (2014).
34. Satchell, S. C., Anderson, K. L. & Mathieson, P. W. Angiopoietin 1 and vascular endothelial growth factor modulate human glomerular endothelial cell barrier properties. J Am Soc Nephrol 15, 566-574 (2004).